- Category: Books » Medicine » Pharmacy
- Format: Hardcover Learn more about the Hardcover format using Tower WIKI.
- Publisher: Springer Verlag
- ISBN: 1588296466
- WAPI (Tower ID): 109324886
- Release Date: October 1, 2008
- Average Customer Review: There are no customer reviews yet. Be the first to write a review!
- Tower.com Sales Rank: #650098 in Books (See Top 100 Books Bestsellers)
- #14910 in Medicine (See Top 100 Medicine Bestsellers)
- #159 in Pharmacy (See Top 100 Pharmacy Bestsellers)
|
|
|
|||||||||||||||||||||||
|
|
Product DescriptionRun a Quick Search on "Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response" by Federico Innocenti to Browse Related Products:Browse more products related to "Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response"Browse more products related to "Federico Innocenti"Publisher's noteThe availability of new molecular approaches to the selection of drug therapy is an emerging need, as the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many, and in most cases the majority of treated patients do not have significant benefits from the treatment while they often experience moderate to severe toxicities. In a oePharmacogenomics, Anticancer Drug Discovery, and Responsea, edited by Federico Innocenti, readers will find a series of chapters addressing the role of genomic information in cancer therapy and in drug development representing a unique source, as it describes experimental approaches, statistical strategies, and clinical examples of the application of genomic medicine in oncology. This book provides the most comprehensive body of knowledge on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. AnnotationThe availability of new molecular approaches to the selection of drug therapy is an emerging need, as the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many, and in most cases the majority of treated patients do not have significant benefits from the treatment while they often experience moderate to severe toxicities. In a oePharmacogenomics, Anticancer Drug Discovery, and Responsea, edited by Federico Innocenti, readers will find a series of chapters addressing the role of genomic information in cancer therapy and in drug development representing a unique source, as it describes experimental approaches, statistical strategies, and clinical examples of the application of genomic medicine in oncology. This book provides the most comprehensive body of knowledge on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. If You Enjoy "Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Hardcover)", May We Also Recommend:Customer Reviews for "Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Hardcover)" by Federico Innocenti (Editor)There are no customer reviews yet. Be the first to write a review! Pharmacy Bestsellers
Medicine Bestselling Books
Explore More Great Tower Sales & Specials
Books Bestsellers
| |||||||||||||||||||||||||||||||||||||
|
